Abstract:A new leukaemia model has been established in mice by deleting the Pten tumour suppressor gene in fetal liver haematopoietic stem cells. The mice develop a myeloproliferative disorder that can lead to acute T lymphoblastic leukaemia. Progression of the condition is driven by leukaemia stem cells that require beta-catenin and incorporate a translocation that leads to overexpression of the c-myc oncogene, similar to findings in human acute T lymphoblastic leukaemia. The study illustrates how multiple genetic alterations can dictate hyperproliferative disorders and the progression to cancer. The loss of the Pten tumour suppressor in haematopoietic stem cells can lead to acute T lymphoblastic leukemia. This study illustrates how multi-genetic alterations can dictate hyperproliferative disorders and the progression to cancer. Cancer stem cells, which share many common properties and regulatory machineries with normal stem cells, have recently been proposed to be responsible for tumorigenesis and to contribute to cancer resistance1. The main challenges in cancer biology are to identify cancer stem cells and to define the molecular events required for transforming normal cells to cancer stem cells. Here we show that Pten deletion in mouse haematopoietic stem cells leads to a myeloproliferative disorder, followed by acute T-lymphoblastic leukaemia (T-ALL). Self-renewable leukaemia stem cells (LSCs) are enriched in the c-KitmidCD3+Lin- compartment, where unphosphorylated β-catenin is significantly increased. Conditional ablation of one allele of the β-catenin gene substantially decreases the incidence and delays the occurrence of T-ALL caused by Pten loss, indicating that activation of the β-catenin pathway may contribute to the formation or expansion of the LSC population. Moreover, a recurring chromosomal translocation, T(14;15), results in aberrant overexpression of the c-myc oncogene in c-KitmidCD3+Lin- LSCs and CD3+ leukaemic blasts, recapitulating a subset of human T-ALL. No alterations in Notch1 signalling are detected in this model, suggesting that Pten inactivation and c-myc overexpression may substitute functionally for Notch1 abnormalities2,3, leading to T-ALL development. Our study indicates that multiple genetic or molecular alterations contribute cooperatively to LSC transformation.

PTEN Maintains Haematopoietic Stem Cells and Acts in Lineage Choice and Leukaemia Prevention

Pten Dependence Distinguishes Haematopoietic Stem Cells from Leukaemia-Initiating Cells

Pten In Regulating Hematopoiesis And Leukemogenesis

Methods for Pten in Stem Cells and Cancer Stem Cells

Pten Loss in Hematopoietic Stem Cells Leads to A Myeloproliferative Disorder

Pten is Necessary for the Quiescence and Maintenance of Adult Muscle Stem Cells

Suppression of Leukemia Development Caused by Pten Loss

Chemoresistant Leukemia-Initiating Cell Expansion is Inhibited by Targeting Oncogenic Self-Renewal

Regulation of the tumor suppressor PTEN by natural anticancer compounds

Overcoming Wnt–β-catenin Dependent Anticancer Therapy Resistance in Leukaemia Stem Cells

Pten Negatively Regulates Neural Stem Cell Self-Renewal By Modulating G(0)-G(1) Cell Cycle Entry

Multi-genetic Events Collaboratively Contribute to Pten -Null Leukaemia Stem-Cell Formation

PTENless means more.

PTEN/PTENP1: ‘Regulating the regulator of RTK-dependent PI3K/Akt signalling’, new targets for cancer therapy

PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype

PTEN Regulates Hematopoietic Lineage Plasticity Via PU.1-dependent Chromatin Accessibility.

PI3Kγ maintains the self-renewal of acute myeloid leukemia stem cells by regulating the pentose phosphate pathway

Adaptive Endoplasmic Reticulum Stress Signalling Via IRE1α–XBP1 Preserves Self-Renewal of Haematopoietic and Pre-Leukaemic Stem Cells

PTENα functions as an immune suppressor and promotes immune resistance in PTEN-mutant cancer

Pten Modulates Cell Cycle Progression and Cell Survival by Regulating Phosphatidylinositol 3,4,5,-Trisphosphate and Akt Protein Kinase B Signaling Pathway

Abstract LB-24: C-terminal PTEN is Essential for Maintenance of Genomic Stability and Tumor Suppression